ST Pharm Co.,Ltd. (KOSDAQ:237690)
94,000
+2,600 (2.84%)
Sep 19, 2025, 3:30 PM KST
ST Pharm Market Cap
ST Pharm has a market cap or net worth of 1.89 trillion as of September 19, 2025. Its market cap has decreased by -6.10% in one year.
Market Cap
1.89T
Enterprise Value
1.92T
Revenue
298.11B
Ranking
n/a
PE Ratio
55.74
Stock Price
94,000.00
Market Cap Chart
Since June 23, 2016, ST Pharm's market cap has increased from 902.04B to 1.89T, an increase of 110.01%. That is a compound annual growth rate of 8.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 1,894.37B | 5.83% |
Dec 30, 2024 | 1,790.03B | 40.37% |
Dec 28, 2023 | 1,275.23B | -22.60% |
Dec 29, 2022 | 1,647.65B | -36.55% |
Dec 30, 2021 | 2,596.92B | 34.10% |
Dec 30, 2020 | 1,936.49B | 248.32% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 72.88T |
Celltrion | 37.63T |
ALTEOGEN | 25.25T |
SK Biopharmaceuticals | 8,888.55B |
Yuhan | 8,872.07B |
Peptron | 6,750.37B |
PharmaResearch | 6,202.62B |
ABL Bio | 5,910.48B |